VAXX: Vaxxinity, Inc. Stock

by  •  • Comments Off on VAXX: Vaxxinity, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 14.92
Enterprise Value ($M) 25.16
Book Value ($M) 13.41
Book Value / Share 0.11
Price / Book 1.11
NCAV ($M) 2.33
NCAV / Share 0.02
Price / NCAV 6.41

Profitability (mra)
Return on Invested Capital (ROIC) -1.99
Return on Assets (ROA) -0.67
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio 1.89
Current Ratio 1.89

Balance Sheet (mrq) ($M)
Current Assets 33.23
Assets 44.31
Liabilities 30.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -58.28
Net Income -56.93

Cash Flow Statement (mra) ($M)
Cash From Operations -57.24
Cash from Investing 28.84
Cash from Financing -1.14

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Hu Mei Mei 70.50 2.13
02-12 13G/A Reese Lou 9.40 10.26
02-07 13G/A Prime Movers Lab Fund I LP 1.06 -93.03

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES
2023-11-08 10-Q UNITED STATES
2023-08-09 10-Q UNITED STATES
2023-05-09 10-Q UNITED STATES

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 336,840 237,183 142.02
2024-04-25 449,168 378,728 118.60
2024-04-24 802,012 887,898 90.33
2024-04-23 445,073 559,151 79.60

(click for more detail)

Similar Companies
TSBX – Turnstone Biologics Corp. TVTX – Travere Therapeutics, Inc.
URGN – UroGen Pharma Ltd. VCEL – Vericel Corporation
VERA – Vera Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io